MedTrace Logo

Multidisciplinary Research Into the Effects of Resistance Exercise and Whey Protein Supplementation in Healthy Older Men

NCT03299972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2019-07-26

No results posted yet for this study

Summary

The aim of this randomised, double-blind, placebo-controlled, parallel groups trial is to investigate the effects of 12 weeks resistance exercise and whey protein supplementation on energy metabolism, markers of appetite, inflammation and hormonal response and body composition and strength and functional performance.

Generally healthy, retired men aged 60-80 years will be recruited (n = 52 in total, n = 13 per group). Participants will be randomised to either: a) control group, b) whey protein supplement group, c) resistance exercise + control group or d) resistance exercise + whey protein supplementation group.

Conditions

Interventions

DIETARY_SUPPLEMENT

Whey Protein

25 g whey protein supplementation twice daily (breakfast and lunch)

DIETARY_SUPPLEMENT

Control

23.75 g maltodextrin twice daily (breakfast and lunch)

OTHER

Resistance Exercise

60 minutes of resistance exercise twice a week

Sponsors & Collaborators

  • University Hospitals Coventry and Warwickshire NHS Trust

    collaborator OTHER

  • Coventry University

    lead OTHER

Principal Investigators

  • Derek Renshaw, PhD · Coventry University

  • John Hattersley, PhD · University Hosptials Coventry and Warwickshire NHS Trust

  • Michael Duncan, PhD · Coventry University

  • Corbin Griffen, MSc · Coventry University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-27
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03299972 on ClinicalTrials.gov